Literature DB >> 25670489

Diabetes, cardiovascular morbidity, and risk of age-related macular degeneration in a primary care population.

Zdravko P Vassilev1, Ana Ruigómez2, Montse Soriano-Gabarró3, Luis A García Rodríguez2.   

Abstract

PURPOSE: Age-related macular degeneration (AMD) is the most common cause of legal blindness in Western patients over 65 years of age. We aimed to establish the incidence of AMD, and the association of diabetes, and cardiovascular and eye diseases with the risk of AMD, in a large cohort of primary care patients in the United Kingdom.
METHODS: Using data from The Health Improvement Network database in the United Kingdom, all individuals with a first recorded diagnosis of AMD from 2004 to 2010 were identified (N = 10,516) and frequency-matched to 19,389 AMD-free individuals by age, sex, and calendar year of AMD occurrence. Logistic regression was used to examine comorbidities and risk factors for AMD.
RESULTS: The incidence of AMD was 18.08 (95% confidence interval [CI], 17.74-18.43) per 10,000 person-years. A positive association with AMD was observed for smoking, a high frequency of primary care visits, and referrals. Diabetes and use of antidiabetic drugs were associated with an increased risk of AMD. Prevalence of cardiovascular diseases among AMD patients was slightly higher than in controls, with a small increased risk of AMD among patients with myocardial infarction, heart failure, or hyperlipidemia. Positive associations were observed between prior eye diseases and risk of AMD, in particular for chorioretinal disorders.
CONCLUSIONS: The incidence of AMD in the United Kingdom is in line with previously reported incidence rates from population-based studies. The study suggests an association between diabetes, prior eye diseases, cardiovascular comorbidities and AMD risk, and a link between AMD and higher healthcare utilization. Copyright 2015 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  age-related macular degeneration; cardiovascular; diabetes; healthcare use

Mesh:

Year:  2015        PMID: 25670489     DOI: 10.1167/iovs.14-16271

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

1.  Visual and Morphologic Outcomes in Eyes with Hard Exudate in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Authors:  Ebenezer Daniel; Juan E Grunwald; Benjamin J Kim; Maureen G Maguire; Glenn J Jaffe; Cynthia A Toth; Frederick L Ferris; Daniel F Martin; James Shaffer; Gui-Shuang Ying
Journal:  Ophthalmol Retina       Date:  2017 Jan-Feb

2.  Association of metformin and development of dry age-related macular degeneration in a U.S. insurance claims database.

Authors:  Emily A Eton; Thomas J Wubben; Cagri G Besirli; Peiying Hua; Brendan McGeehan; Brian L VanderBeek
Journal:  Eur J Ophthalmol       Date:  2021-02-19       Impact factor: 2.597

Review 3.  Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.

Authors:  Katie L Pennington; Margaret M DeAngelis
Journal:  Eye Vis (Lond)       Date:  2016-12-22

4.  Choroidal microvascular proliferation secondary to diabetes mellitus.

Authors:  Rui Hua; Qing Li; Ian Yat Hin Wong; Hong Ning; Hailin Wang
Journal:  Oncotarget       Date:  2017-01-10

5.  Advances in Age-related Macular Degeneration Understanding and Therapy.

Authors:  Joan W Miller; Saghar Bagheri; Demetrios G Vavvas
Journal:  US Ophthalmic Rev       Date:  2017

6.  Association of HTRA1 and ARMS2 gene polymorphisms with response to intravitreal ranibizumab among neovascular age-related macular degenerative subjects.

Authors:  Nur Afiqah Mohamad; Vasudevan Ramachandran; Hazlita Mohd Isa; Yoke Mun Chan; Nor Fariza Ngah; Siew Mooi Ching; Fan Kee Hoo; Wan Aliaa Wan Sulaiman; Liyana Najwa Inche Mat; Mohd Hazmi Mohamed
Journal:  Hum Genomics       Date:  2019-02-22       Impact factor: 4.639

7.  Medical Compliance of Fibrate and the Decreased Risk of Age-Related Macular Degeneration in Dyslipidemia-Related Diseases: A Population-Based Cohort Study.

Authors:  Kai Wang; Ming-Ju Hsieh; Hsiang-Wen Chien; Chia-Yi Lee; Chao-Bin Yeh; Jing-Yang Huang; Shun-Fa Yang
Journal:  Int J Environ Res Public Health       Date:  2021-01-03       Impact factor: 3.390

8.  Effect of curcumin on aging retinal pigment epithelial cells.

Authors:  Wei Zhu; Yan Wu; Yi-Fang Meng; Jin-Yu Wang; Ming Xu; Jian-Jun Tao; Jiong Lu
Journal:  Drug Des Devel Ther       Date:  2015-09-25       Impact factor: 4.162

Review 9.  Stem Cell Therapy for Treatment of Ocular Disorders.

Authors:  Padma Priya Sivan; Sakinah Syed; Pooi-Ling Mok; Akon Higuchi; Kadarkarai Murugan; Abdullah A Alarfaj; Murugan A Munusamy; Rukman Awang Hamat; Akihiro Umezawa; Suresh Kumar
Journal:  Stem Cells Int       Date:  2016-05-15       Impact factor: 5.443

Review 10.  Ocular progenitor cells and current applications in regenerative medicines - Review.

Authors:  K Gokuladhas; N Sivapriya; M Barath; Charles H NewComer
Journal:  Genes Dis       Date:  2017-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.